EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-2-one, an Intracellular Inhibitor of PIM-1 Kinase in Acute Lymphoblastic Leukemia and Breast Cancer Cells

Patrycja Wińska, Monika Wielechowska, Łukasz Milewski, Paweł Siedlecki iD, Edyta Łukowska-Chojnacka iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Patrycja Wińska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-pim-1, Apoptosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research was funded by (POB Biotechnology and biomedical engineering) of Warsaw University of Technology within the Excellence Initiative: Research University…, POB Biotechnology and Biomedical Engineering of Warsaw University of Technology within the Excellence Initiative: Research University (IDUB) program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibition of CK2 and/or PIM-1 kinases has been shown to induce apoptosis in a variety of cancer cell lines, underscoring their potential as valuable targets in anti-cancer drug development. In this study, a series of N-substituted derivatives of 4,5,6,7-tetrabromo-1H-benzimidazole, including 2-oxopropyl/2-oxobutyl substituents and their respective hydroxyl analogues, were synthesized and evaluated for anti-cancer activity. The compounds’ ability to inhibit CK2α and PIM-1 kinases was assessed through enzymatic assays, complemented by comprehensive in silico enzyme–substrate docking analyses. Cytotoxicity was evaluated using the MTT assay in human cancer cell lines—including acute lymphoblastic leukemia (CCRF-CEM) and breast cancer (MCF-7, MDA-MB-231)—as well as in normal Vero cells. Apoptosis induction in the two most responsive cell lines (CCRF-CEM and MCF-7) was further examined using flow cytometry-based assays, including annexin V binding, mitochondrial membrane potential disruption, caspase-3 activation, and cell cycle analysis. Intracellular inhibition of CK2 and PIM-1 kinases was confirmed in CCRF-CEM and MCF-7 cells using Western blot and phospho-flow cytometry. Among the synthesized compounds, we identified a novel TBBi derivative exhibiting pronounced pro-apoptotic activity and the ability to inhibit PIM-1 kinase intracellularly. These findings support the hypothesis that PIM-1 kinase represents a promising molecular target for the treatment of leukemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-pim-1ApoptosisPrecursor Cell Lymphoblastic Leukemia-LymphomaBreast NeoplasmsProtein Kinase InhibitorsBenzimidazolesAntineoplastic AgentsHumansFemaleCell Line, TumorMCF-7 CellsMolecular Docking SimulationAnimalsChlorocebus aethiopsCasein Kinase IIVero CellsCell Proliferation

Stichwörter der Autor:innen

PIM kinaseTBBi derivativesanti-tumor activitybreast cancerleukemiaprotein kinase CK2

Substanzen

Proto-Oncogene Proteins c-pim-1Protein Kinase InhibitorsBenzimidazolesAntineoplastic AgentsCasein Kinase IIPIM1 protein, human

Autor:innen und Institutionen

  • Faculty of Chemistry, Warsaw University of Technology, Noakowskiego St. 3, 00-664 Warsaw, Poland.
  • Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego St. 5A, 02-106 Warsaw, Poland.

ORCID-Profile: Paweł Siedlecki, Edyta Łukowska-Chojnacka

Förderung

  • Research was funded by (POB Biotechnology and biomedical engineering) of Warsaw University of Technology within the Excellence Initiative: Research University…
  • POB Biotechnology and Biomedical Engineering of Warsaw University of Technology within the Excellence Initiative: Research University (IDUB) program

Zitieren

APA

Wińska, P., Wielechowska, M., Milewski, Ł., Siedlecki, P., & Łukowska-Chojnacka, E. (2025). Pro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-2-one, an Intracellular Inhibitor of PIM-1 Kinase in Acute Lymphoblastic Leukemia and Breast Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125897

Vancouver

Wińska P, Wielechowska M, Milewski Ł, Siedlecki P, Łukowska-Chojnacka E. Pro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-2-one, an Intracellular Inhibitor of PIM-1 Kinase in Acute Lymphoblastic Leukemia and Breast Cancer Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125897

BibTeX
@article{Wiska2025,
  author = {Wińska, Patrycja and Wielechowska, Monika and Milewski, Łukasz and Siedlecki, Paweł and Łukowska-Chojnacka, Edyta},
  title = {Pro-Apoptotic Activity of 1-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-2-one, an Intracellular Inhibitor of PIM-1 Kinase in Acute Lymphoblastic Leukemia and Breast Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125897}
}
Kostenlos starten →